Valsts: Īrija
Valoda: angļu
Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)
CHLORHEXIDINE GLUCONATE
Eastern Pharmaceuticals Limited
CHLORHEXIDINE GLUCONATE
0.1 %w/v
Cutaneous Solution
Product not subject to medical prescription
Authorised
0000-00-00
PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Cepton Medicated Lotion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient: Chlorhexidine Gluconate 0.1 % w/v (incorporated as Chlorhexidine Gluconate Solution BP 0.5 % v/v) _For excipients, see Section 6.1_ 3 PHARMACEUTICAL FORM Cutaneous solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS An aid in the treatment of spots and acne. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Apply morning and night as follows: ○ After washing - Moisten a cotton wool pad with Medicated Lotion and apply to the face, particularly around the nose, forehead and chin. Do not rinse off. ○ After shaving - Pour Medicated Lotion into the hands and splash onto the face ○ During the day - Moisten a pad or tissue with Medicated Lotion and apply to oily areas to cleanse, ton and remove greasy patches as they appear. 4.3 CONTRAINDICATIONS None known. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE For external use only Keep all medicines away from children Keep out of the eyes Flammable 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION None known. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 28/05/2010_ _CRN 2083457_ _page number: 1_ 4.6 PREGNANCY AND LACTATION No known restrictions. 4.7 EFFECTS ON ABILITY TO DRIVE AND USE MACHINES The ability to drive or use machines is not affected. 4.8 UNDESIRABLE EFFECTS None known. 4.9 OVERDOSE Not applicable. 5 PHARMACOLOGICAL PROPERTIES 5.1 PHARMACODYNAMIC PROPERTIES Chlorhexidine is an effective antiseptic with a wide range of activities against micro-organisms, including gram positive and gram negative bacteria, fungi and viruses. 5.2 PHARMACOKINETIC PROPERTIES Not app Izlasiet visu dokumentu